Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 8Unknown 5Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2Pain 1Meningioma 1Emergence Delirium 1Delirium 1

Interventions

Temozolomide 20Magnetic Resonance Spectroscopy 10Radiotherapy 9Blood Specimen Collection 8pembrolizumab 6Cyclophosphamide 6Bevacizumab 6AZD 6244 6Radiation 5Specimen Handling 4vorasidenib 3fludarabine 3cemiplimab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2dinutuximab 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Dexmedetomidine × CNS × Clear all
NCT07398066 2026-02-09

DEX-NEURO

University of Malaya

Phase NA Not yet recruiting
60 enrolled
CNS

Brain Neoplasms, Delirium, Meningioma, Pain

NCT06863064 2025-03-07

Brain Tumor Surgery and Postoperative Delirium

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase NA Not yet recruiting
140 enrolled
CNS

Emergence Delirium, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡